Streetbeat News

Equity Actions

CRSP

DKNG

NTLA

TSLA

Ark Invest, led by Cathie Wood, has sold nearly $10M worth of Tesla Inc shares for the second consecutive day. The shares were sold through the ARK Innovation ETF fund. On the previous day, Ark Invest sold over $8M worth of Tesla shares. Ark Invest also purchased shares of PagerDuty Inc, CRISPR Therapeutics AG, and Intellia Therapeutics Inc, and sold shares of DraftKings Inc.

Portfolio Pulse from Benzinga Neuro

October 12, 2023 | 2:38 am

BIRK

MSFT

NVO

TPST

TSLA

Major U.S. stock indices ended in the green on Wednesday, with the Nasdaq Composite marking notable gains. Tempest Therapeutics soared by 1470.83% after unveiling updated results from an ongoing Phase 1b/2 study. Microsoft experienced a 1.23% increase after unveiling new AI initiatives aimed at supporting the healthcare industry. Birkenstock faced a downturn of -12.61% after its IPO. Novo Nordisk marked a 6.27% increase after halting the FLOW trial early due to promising results. Tesla saw a slight decline of -0.24% after unveiling a new video ad campaign.

Portfolio Pulse from Benzinga Neuro

October 12, 2023 | 2:16 am

RGF

The Real Good Food Company, Inc. (NASDAQ:RGF) has priced an underwritten public offering of 6,785,715 shares of its Class A common stock at $2.10 per share, expecting to raise approximately $14.3 million. The proceeds will be used for general corporate purposes. The company has also granted underwriters a 30-day option to purchase an additional 1,017,857 shares. The offering is expected to close on October 16, 2023.

Portfolio Pulse from Charles Gross

October 11, 2023 | 11:22 pm

ATXS

Astria Therapeutics has priced an underwritten offering of 8,253,895 shares of its common stock and accompanying common stock warrants to purchase an aggregate of 6,190,418 shares of common stock at $6.514. The offering also includes pre-funded warrants to purchase up to an aggregate of 1,571,093 shares of common stock and accompanying common stock warrants to purchase up to an aggregate of 1,178,320 shares of common stock. The aggregate gross proceeds of the offering are expected to be approximately $64 million. The offering is expected to close on October 16, 2023.

Portfolio Pulse from Charles Gross

October 11, 2023 | 11:20 pm

ABNB

Despite high mortgage rates, real estate investor Sam Primm continues to buy houses using the BRRRR strategy (buy, rehab, rent, refinance, repeat). He increases a property's value through renovations, refinances it under a traditional mortgage, and rents it out, effectively having someone else pay for it. Primm adjusts his strategy as the housing market changes to remain cash flow positive. He also suggests using Airbnb Inc (NASDAQ:ABNB) for short-term rentals if long-term tenancy isn't profitable enough.

Portfolio Pulse from Adam Eckert

October 11, 2023 | 10:42 pm

ITOS

NATLw

NCR Atleos is set to join the S&P SmallCap 600, replacing iTeos Therapeutics. The change will be effective prior to the opening of trading on October 18.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 9:23 pm

SRRK

Scholar Rock has begun a public offering for $75M of its common stock. The company is also planning to give underwriters a 30-day option to buy additional shares equal to 15% of the securities offered in the public offering.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 9:10 pm

CVX

A significant amount of unusual options activity has been detected for Chevron (NYSE:CVX), with a majority of investors taking a bullish stance. The trades range from $125.0 to $200.0 strike price. The price of CVX is currently down -3.27% at $161.1. UBS, Mizuho, and Morgan Stanley have maintained their Buy and Equal-Weight ratings on Chevron, with price targets of $210, $215, and $203 respectively.

Portfolio Pulse from Benzinga Insights

October 11, 2023 | 8:48 pm

GTH

Genetron Holdings has announced a plan to change its ADS ratio from 1-5 to 1-15, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 8:35 pm

RGF

The Real Good Food Company, Inc. (NASDAQ:RGF) shares dropped after the company reported preliminary Q3 results and issued full-year and Q4 revenue guidance below estimates. The company also announced the commencement of a public offering. Full-year 2023 revenue is expected to be between $185 million and $194 million, versus the $202.35 million estimate. Shares of RGF were down 26.1% at $2.29.

Portfolio Pulse from Ryan Gustafson

October 11, 2023 | 8:11 pm